Other
Question
Question is an intervention with 3 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
OTHER
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
1(33%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
1
33%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution1 total trials
N/ANon-phased studies
1(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
3
all time
Status Distribution
Active(2)
Completed(1)
Detailed Status
Recruiting1
Completed1
Not yet recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
1
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A1 (100.0%)
Trials by Status
recruiting133%
completed133%
not_yet_recruiting133%
Recent Activity
1 active trials
Showing 3 of 3
completed
A Comparison of CoolStick With Ethyl Chloride for the Assessment of Light Touch
NCT06596486
not_yet_recruitingnot_applicable
A Study Comparing Two Mandibular Advancement Devices in the Treatment of Sleep Apnea
NCT06810479
recruiting
Bezafibrate in Patients With Primary Biliary Cholangitis (PBC)
NCT04514965
Clinical Trials (3)
Showing 3 of 3 trials
NCT06596486
A Comparison of CoolStick With Ethyl Chloride for the Assessment of Light Touch
NCT06810479Not Applicable
A Study Comparing Two Mandibular Advancement Devices in the Treatment of Sleep Apnea
NCT04514965
Bezafibrate in Patients With Primary Biliary Cholangitis (PBC)
All 3 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 3